Prospective, Open-Label, Randomized Control Trial on Pharmacokinetics of Direct Oral Anticoagulant (Apixaban) in Prevention of Primary Nephrotic Syndrome Associated Thromboembolic Disease (RBWH admin) (2022–2023)

Grant type:
Metro North Hospital and Health Service
Researchers:
  • NHMRC Leadership Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
Funded by:
Metro North Hospital and Health Service